Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Lepu Biopharma Co. Ltd. Class H ( (HK:2157) ).
Lepu Biopharma Co., Ltd. has announced amendments to its Articles of Association following the issuance of new H Shares, as approved by the China Securities Regulatory Commission. This move, which increases the company’s registered capital, is part of a broader strategy to enhance its capital structure and strengthen its market positioning.
The most recent analyst rating on (HK:2157) stock is a Sell with a HK$5.00 price target. To see the full list of analyst forecasts on Lepu Biopharma Co. Ltd. Class H stock, see the HK:2157 Stock Forecast page.
More about Lepu Biopharma Co. Ltd. Class H
Lepu Biopharma Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biopharmaceutical industry. The company is involved in the issuance of H Shares on the Hong Kong Stock Exchange, reflecting its focus on expanding its capital structure and market presence.
Average Trading Volume: 14,480,977
Technical Sentiment Signal: Hold
Current Market Cap: HK$10.72B
See more data about 2157 stock on TipRanks’ Stock Analysis page.